Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shanghai Huaota Biopharmaceutical Co., Ltd. (Huaota), established in 2013, is a subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd. Focused on innovation-driven biologics development, Huaota has built integrated R&D and pilot-scale manufacturing platforms supporting monoclonal antibodies, bispecific antibodies, fusion proteins, and ADCs. Its GMP-compliant DS and DP pilot facilities, licensed in 2020, utilize advanced dispos...
Shanghai Huaota Biopharmaceutical Co., Ltd. (Huaota), established in 2013, is a subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd. Focused on innovation-driven biologics development, Huaota has built integrated R&D and pilot-scale manufacturing platforms supporting monoclonal antibodies, bispecific antibodies, fusion proteins, and ADCs. Its GMP-compliant DS and DP pilot facilities, licensed in 2020, utilize advanced disposable bioreactor technology and high-capacity filling lines. A fully equipped quality control laboratory supports product release, stability studies, registration, and clinical trials.

List your booth number for exhibitions, ask us